Search companies or stocks...
Tekla Life Sciences Investors (HQL) current market price $20.98; calculated gap vs modeled fair value is 0.97%. The dollar intrinsic value estimate is available with Tickerplace Pro.
Confidence score is based on the magnitude of the gap vs the modeled estimate.
Fair value estimate
Unlock fair valueCurrent price
$20.98
For Tekla Life Sciences Investors, intrinsic value ties fair value to sustainable cash generation and compares that level with the live market price.
Historical valuation for HQL shows cycles where multiples expanded and compressed; today’s positioning is one data point in that range.
The gap comes down to growth, risk, and return on capital in the models. Cross-check with live ratios and financials linked from this page.
Tekla Life Sciences Investors (HQL) current market price is $20.98, a calculated difference of 1.0% versus modeled fair value. Tickerplace Pro unlocks the dollar intrinsic value estimate. This is a model output, not a recommendation.
Intrinsic value is an estimate of what HQL shares may be worth based on fundamentals rather than today's price alone. See the valuation snapshot on this page for the latest model output. Tickerplace Pro unlocks the full dollar fair value estimate.
Tickerplace calculates HQL's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to show the calculated gap.
HQL’s calculated gap versus modeled fair value is 1.0% at a market price of $20.98. A gap is a calculated difference between price and the model estimate, not a buy or sell conclusion. Confirm with ratios and financials on the company profile.
Peers for HQL: open their calculated fair value vs price view.
